• Register
  • Login
  • Subscribe
  • Contact Us

Lacosamide-Ethomidate-And Other-Pharmacy

ArgentinaTenders notice for Lacosamide-Ethomidate-And Other-Pharmacy. The reference ID of the tender is 118951770 and it is closing on 15 May 2025.

Tender Details

  • Country: Argentina
  • Summary: Lacosamide-Ethomidate-And Other-Pharmacy
  • ART Ref No: 118951770
  • Deadline: 15 May 2025
  • Financier: Self Financed
  • Purchaser Ownership: Government
  • Tender Value: ARS 145117515.80
  • Notice Type: Tender
  • Document Ref. No.: 430-0655-LPU25
  • Purchaser's Detail:
    Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
  • Description:
  • Lacosamide Model: 100 mg, in covered tablet, lacosamide. Model: 50 mg, in compressed, lacosamide. Model: 200 mg, in covered tablet, etomidato. Model: 20 mg, injectable, in ampoule x 20 ml, lighttam. Model: 500 mg, in ampoule, pramipexol. Model: 1 mg,In tablet, amantadine. Model: 100 mg (as hydrochloride), on tablet, diacerein. Model: 50 mg, in capsule, Godmina + Hesperidine. Model: 450 mg of Godmina + 50 mg of hesperidine, in covered tablet, tranexamic acid. Model: 500 mg, injectable solution, in ampoule x 5ml, teriparatide. Model: 250 yg/ml, of recombinant DNA origin, injectable solution, in cartridge x 3 ml, zoledronic acid. Model: 5 mg, in Amprola, rifaximin bottle. Model: 550 mg, in tablets, polyethylene glycol 3350. Model: 17 g, on individual, paracetamol. Model: 1000mg, 10 mg x ml, intravenous injectable, in 100 ml blister bottle, phosphate sodium solution. Model: With 3 mmol of phosphorus and 4 mEq of sodium per milliliter, in ampoule x 10 ml, intravenous, sterile and apirogenic use, amitriptyline model: 25 mg (as hydrochloride), in covered tablet, electriptanOther specifications will be indicated by the requesting distribution. Model: 40 mg., In tablets., Betahistine dichlorhydrate. Model: 16 mg, in tablet, diclofenac + pridinol. Model: 1.45 g of diclofenac + 0.34 g of mesilate pridinol, cream, in pomo x 50 g, fluoresceinSOD...
  • Documents:

 Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

Lacosamide-Ethomidate-And Other-Pharmacy - Argentina Tender

The HTAL. JOSE M. WE MEJIA, a Government sector organization in Argentina, has announced a new tender for Lacosamide-Ethomidate-And Other-Pharmacy. This tender is published on ArgentinaTenders under ART Ref No: 118951770 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-15.

The estimated tender value is ARS 145117515.80, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.

ArgentinaTenders Features

ArgentinaTenders Features

Fresh and verified Tenders from Argentina. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • New Tenders Every Day
  • Tenders Result Data
  • Archive & Historical Tenders Access
  • Consultants for RFI/RFP/RFQ
  • Tender Notifications & Alerts
  • Search, Sort, and Filter Tenders
  • Bidding Assistance & Consulting
  • Customer Support
  • Publish your Tenders
  • Export data to Excel
  • API for Tender Data
  • Tender Documents
Tender Experts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ArgentinaTenders !!
Email Id is already exist !!
Captcha Image
Invalid Captcha !

Get FREE SAMPLE TENDERS from Argentina in your email inbox.

  Chat with us